PIG Stock Overview
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally.
Snowflake Score | |
---|---|
Valuation | 6/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 4/6 |
Perrigo Company plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$28.35 |
52 Week High | US$36.25 |
52 Week Low | US$24.08 |
Beta | 0.62 |
1 Month Change | -3.87% |
3 Month Change | -1.19% |
1 Year Change | -10.79% |
3 Year Change | -19.00% |
5 Year Change | -32.82% |
Change since IPO | -74.54% |
Recent News & Updates
Recent updates
Shareholder Returns
PIG | DE Pharmaceuticals | DE Market | |
---|---|---|---|
7D | 2.4% | 4.0% | 2.5% |
1Y | -10.8% | -24.6% | 7.0% |
Return vs Industry: PIG exceeded the German Pharmaceuticals industry which returned -25.9% over the past year.
Return vs Market: PIG underperformed the German Market which returned 7.3% over the past year.
Price Volatility
PIG volatility | |
---|---|
PIG Average Weekly Movement | 5.5% |
Pharmaceuticals Industry Average Movement | 6.3% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.1% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: PIG has not had significant price volatility in the past 3 months.
Volatility Over Time: PIG's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1887 | 9,140 | Patrick Lockwood-Taylor | https://www.perrigo.com |
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Perrigo Company plc Fundamentals Summary
PIG fundamental statistics | |
---|---|
Market cap | €3.94b |
Earnings (TTM) | -€4.06m |
Revenue (TTM) | €4.30b |
0.9x
P/S Ratio-968.9x
P/E RatioIs PIG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PIG income statement (TTM) | |
---|---|
Revenue | US$4.66b |
Cost of Revenue | US$2.98b |
Gross Profit | US$1.68b |
Other Expenses | US$1.68b |
Earnings | -US$4.40m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.032 |
Gross Margin | 36.09% |
Net Profit Margin | -0.094% |
Debt/Equity Ratio | 85.4% |
How did PIG perform over the long term?
See historical performance and comparison